September 5, 2002

FOR: ZOLL Medical Corporation

Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655
PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832


ZOLL Medical and Premedics Announce Agreement

Thursday, September 05, 2002 – ZOLL Medical Corporation (Nasdaq: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices, today announced a multi-year, national agreement with Premedics™ Inc., a leading AED services provider, to keep automated external defibrillators (AEDs) and trained staff at a high state of readiness and optimize Public Access Defibrillation (PAD) programs.

Premedics will offer ZOLL AED Plus customers its “AED Expert On-Site” suite of services which includes medical direction, implementation, training, and other support services in addition to their patent-pending, intelligent, web-based services system, AED Managerä. AED Manager notifies users when critical actions must be taken—such as replacing defibrillator pads, updating training certifications, and ensuring trained staff is always available to handle medical emergencies. In addition, AED Manager issues monthly reports to each program site, as well as a summary “READY Report™” to corporate headquarters.

The ZOLL AED Plus is the first automated external defibrillator to feature a combination of simple, step-by-step illustrations and audio coaching. These features help to make a stressful and challenging medical crisis a more manageable and controlled rescue, especially for trained individuals not routinely responsible for responding to victims of sudden cardiac arrest. The ZOLL AED Plus helps the rescuer more calmly think through the appropriate steps and administer necessary life-saving treatment, as defined by the American Heart Association guidelines.

“Appropriate administration and constant readiness of AED and PAD programs is vital to their success in the workplace and other public venues,” said Richard A. Packer, president and chief executive officer of ZOLL. “Premedics’ AED Manager provides a valuable service to our customers by simplifying the process, helping to ensure that each device and trained rescuer is always ready, in case of emergency. This partnership allows ZOLL to offer these critical training and medical control services to the growing AED Plus customer base throughout the United States.”

AEDs are used to treat sudden cardiac arrest resulting from ventricular fibrillation (VF), a spontaneous, mostly fatal interruption of normal heartbeat and a leading cause of death in the United States. The American Heart Association (AHA) estimates that as many as 49% of the approximately 400,000 people who die from sudden cardiac arrest each year could be saved with public access defibrillation, the placement of defibrillators into the community for use by trained laypersons and first responders. According to the AHA, “Public access defibrillation, which places AEDs in the hands of trained laypersons, has the potential to be the single greatest advance in the treatment of VF cardiac arrest since the development of CPR.”

“ZOLL has a great reputation in the resuscitation field and a very exciting new AED,” said Brent Hetherington, founder and chief executive officer of Premedics. “We’re pleased to partner with them and offer their customers nationwide our AED Expert On Site as well as implementation, training and other support services. Our objective is for companies to always be ready to save lives.”

Treating victims with controlled electric shocks administered by AEDs during the first critical minutes after sudden cardiac arrest (SCA) occurs is the primary way to restore the heart’s normal rhythm—and prevent brain death. The American Heart Association recently launched Operation Heartbeat, a national,
community-based initiative designed to increase AED availability and usage and improve survival rates from SCA.

About Premedics
Premedics, established in 1998 and headquartered in Nashville, Tennessee, provides comprehensive support services that simplify AED and PAD program implementation, medical oversight, maintenance and compliance issues. Premedics is able to provide services in all 50 states and currently serves users at 600 locations in 33 states. During the first two quarters of 2002, Premedics clients used their AEDs to save 13 lives. For more information, visit

About ZOLL Medical Corporation
ZOLL Medical Corporation, headquartered in Burlington, MA, designs,
manufactures and markets an integrated line of proprietary, non-invasive
resuscitation devices and disposable electrodes. Used by health care professionals to provide both types of cardiac resuscitation—pacing and defibrillation—these products are essential in the emergency treatment of cardiac arrest victims, both inside and outside the hospital. ZOLL also designs and markets software that automates collection and management of both clinical and non-clinical data for emergency medical service providers. ZOLL has operations in the United States, Canada, United Kingdom, Germany, France, the Netherlands and Australia, and business partners in all of the world’s major markets. For more information about ZOLL and its products, visit

Certain statements contained in this press release, including statements regarding the anticipated development of ZOLL’s business, the intent, belief or current expectations of ZOLL, its directors or its officers, primarily with respect to ZOLL’s business model and future operating performance of ZOLL, including expectations regarding results in future periods, operating performance and contributions to results from ZOLL’s new Public Access Defibrillation product, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the ZOLL’s Annual Report on Form 10-Q filed on August 14, 2002, the future performance of the direct sales operations, the outcome of a pending patent infringement suit relating to the ZOLL AED Plus, as well as uncertainties regarding the market, acceptance and profitability of the ZOLL AED Plus and M Series CCT, the length and severity of the current economic slowdown and its impact on capital spending budgets, the reduction in overall capital equipment expenditures in the hospital and pre-hospital markets, the potential disruption in the transportation industry on ZOLL’s supply chain and product distribution channels, and the desire or ability of other parties to purchase the ZOLL’s products.

# # #